Myos Corp., of Cedar Knolls, N.J., closed the initial tranche of the previously announced strategic investment by Rens Technology Inc. In connection with the initial closing, Rens invested $5.25 million and received 1.5 million shares of the company’s common stock and a warrant to purchase 375,000 shares of common stock at $7 per share. The parties intend to conduct two additional closings over the next 24 months for an additional $15 million in gross proceeds. Myos said it intends to use the net proceeds from the initial tranche to fund its working capital, product development and marketing, R&D and other general corporate purposes.